The findings from numerous human and animal studies reviewed above and recapitulated in Figure 2 clearly support the notion that dysregulation in the crosstalk between PPARγ singling and epigenetic effectors plays a significant role in the pathophysiology of NAFLD and its progression stages. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.